Report overview
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine Adjuvants. This report contains market size and forecasts of Veterinary Vaccine Adjuvants in global, including the following market information:
Global Veterinary Vaccine Adjuvants Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Veterinary Vaccine Adjuvants Market Sales, 2018-2023, 2024-2029, (MT)
Global top five Veterinary Vaccine Adjuvants companies in 2022 (%)
The global Veterinary Vaccine Adjuvants market was valued at US$ 340.7 million in 2022 and is projected to reach US$ 510 million by 2029, at a CAGR of 5.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Europe is the largest region of Veterinary Vaccine Adjuvants, with a market share about 35%. It was followed by North America with 30%. SEPPIC, SDA BIO, Brenntag Biosector, SPI Pharma and MVP Laboratories are the top 5 manufacturers of industry, and they had about 70% combined market share.
We surveyed the Veterinary Vaccine Adjuvants manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Vaccine Adjuvants Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Veterinary Vaccine Adjuvants Market Segment Percentages, by Type, 2022 (%)
Oral
Subcutaneous
Intramuscular
Others
Global Veterinary Vaccine Adjuvants Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Veterinary Vaccine Adjuvants Market Segment Percentages, by Application, 2022 (%)
Livestock Vaccines
Companion Animals Vaccines
Global Veterinary Vaccine Adjuvants Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Veterinary Vaccine Adjuvants Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Veterinary Vaccine Adjuvants revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Veterinary Vaccine Adjuvants revenues share in global market, 2022 (%)
Key companies Veterinary Vaccine Adjuvants sales in global market, 2018-2023 (Estimated), (MT)
Key companies Veterinary Vaccine Adjuvants sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
SEPPIC
SDA BIO
Croda International Plc
SPI Pharma
MVP Laboratories
Zhuoyue
Zhiju Bio
Outline of Major Chapters:
Chapter 1: Introduces the definition of Veterinary Vaccine Adjuvants, market overview.
Chapter 2: Global Veterinary Vaccine Adjuvants market size in revenue and volume.
Chapter 3: Detailed analysis of Veterinary Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Veterinary Vaccine Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Veterinary Vaccine Adjuvants capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
